U.S. Department of Justice declared on Tuesday, that a Johnson & Johnson subsidiary pleaded guilty to selling liquid medicine contaminated with metal and agreed to pay $25 million to resolve the case, Reuters reports.
The troubles began in May 2009 when a consumer while using a product of Infant’s Tylenol noticed "black specks" in the bottom of a bottle. The specks were found to be nickel and chromium particles. After the case the sales of Johnson & Johnson reduced by 19 percent, which is $900 million. There is no exact estimation how much this time the loss will be .